Related Experiment Video
Updated: Aug 18, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Regression of oral hairy leukoplakia during zidovudine therapy
H A Kessler1, C A Benson, P Urbanski
1Department of Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612.
Abstract:
We describe two patients with human immunodeficiency virus infection and oral hairy leukoplakia whose tongue lesions resolved on oral zidovudine therapy. During therapy, each patient had a measurable reduction in human immunodeficiency virus antigen corresponding with clinical regression of oral lesions. The clinical course suggests that zidovudine may have contributed to the resolution of these lesions either indirectly through immunologic improvement or through an antiviral effect.
Related Concept Videos
Retrovirus Life Cycles
Herpes
Chickenpox
Genital Herpes
Antiviral Nucleoside Inhibitors

